Gupta I, Adin S, Aqil M, Mujeeb M, Sultana Y
Dermatol Pract Concept. 2022; 12(4):e2022202.
PMID: 36534578
PMC: 9681271.
DOI: 10.5826/dpc.1204a202.
Falotico J, Lipner S
Clin Cosmet Investig Dermatol. 2022; 15:1933-1957.
PMID: 36133401
PMC: 9484770.
DOI: 10.2147/CCID.S362635.
Foley K, Gupta A, Versteeg S, Mays R, Villanueva E, John D
Cochrane Database Syst Rev. 2020; 1:CD012093.
PMID: 31978269
PMC: 6984586.
DOI: 10.1002/14651858.CD012093.pub2.
Hay R
J Fungi (Basel). 2018; 4(3).
PMID: 30127244
PMC: 6162762.
DOI: 10.3390/jof4030099.
Kreijkamp-Kaspers S, Hawke K, Guo L, Kerin G, Bell-Syer S, Magin P
Cochrane Database Syst Rev. 2017; 7:CD010031.
PMID: 28707751
PMC: 6483327.
DOI: 10.1002/14651858.CD010031.pub2.
Spotlight on tavaborole for the treatment of onychomycosis.
Jinna S, Finch J
Drug Des Devel Ther. 2015; 9:6185-90.
PMID: 26640371
PMC: 4662369.
DOI: 10.2147/DDDT.S81944.
Efinaconazole in the treatment of onychomycosis.
Lipner S, Scher R
Infect Drug Resist. 2015; 8:163-72.
PMID: 26082652
PMC: 4459619.
DOI: 10.2147/IDR.S69596.
Pharmacokinetics and bioavailability of itraconazole oral solution in cats.
Liang C, Shan Q, Zhong J, Li W, Zhang X, Wang J
J Feline Med Surg. 2015; 18(4):310-4.
PMID: 25916686
PMC: 11112252.
DOI: 10.1177/1098612X15581408.
Candida parapsilosis and Candida guillermondii: emerging pathogens in nail candidiasis.
Fich F, Abarzua-Araya A, Perez M, Nauhm Y, Leon E
Indian J Dermatol. 2014; 59(1):24-9.
PMID: 24470656
PMC: 3884923.
DOI: 10.4103/0019-5154.123485.
Antifungal activity of four honeys of different types from Algeria against pathogenic yeast: Candida albicans and Rhodotorula sp.
Moussa A, Noureddine D, Saad A, Abdelmelek M, Abdelkader B
Asian Pac J Trop Biomed. 2013; 2(7):554-7.
PMID: 23569970
PMC: 3609343.
DOI: 10.1016/S2221-1691(12)60096-3.
Comparison of superficial mycosis treatment using Butenafine and Bifonazole nitrate clinical efficacy.
Abdul Bari M
Glob J Health Sci. 2013; 5(1):150-4.
PMID: 23283047
PMC: 4776972.
DOI: 10.5539/gjhs.v5n1p150.
Oral treatments for fungal infections of the skin of the foot.
Bell-Syer S, Khan S, Torgerson D
Cochrane Database Syst Rev. 2012; 10:CD003584.
PMID: 23076898
PMC: 7144818.
DOI: 10.1002/14651858.CD003584.pub2.
Update on terbinafine with a focus on dermatophytoses.
Newland J, Abdel-Rahman S
Clin Cosmet Investig Dermatol. 2011; 2:49-63.
PMID: 21436968
PMC: 3047923.
DOI: 10.2147/ccid.s3690.
Effect of itraconazole on the pharmacokinetics of diclofenac in beagle dogs.
Al-Jenoobi F
Sci Pharm. 2010; 78(3):465-71.
PMID: 21179359
PMC: 3002807.
DOI: 10.3797/scipharm.1003-10.
Forty-eight-hour diagnosis of onychomycosis with subtyping of Trichophyton rubrum strains.
Kardjeva V, Summerbell R, Kantardjiev T, Devliotou-Panagiotidou D, Sotiriou E, Graser Y
J Clin Microbiol. 2006; 44(4):1419-27.
PMID: 16597871
PMC: 1448676.
DOI: 10.1128/JCM.44.4.1419-1427.2006.
Dermacase. Dermatophyte infection (tinea).
Turchin I, Barankin B, Alanen K, Saxinger L
Can Fam Physician. 2005; 51:499-501.
PMID: 15856966
PMC: 1472947.
Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors.
Niewerth M, Kunze D, Seibold M, Schaller M, Korting H, Hube B
Antimicrob Agents Chemother. 2003; 47(6):1805-17.
PMID: 12760852
PMC: 155814.
DOI: 10.1128/AAC.47.6.1805-1817.2003.
Which antifungal agent for onychomycosis? A pharmacoeconomic analysis.
Joish V, Armstrong E
Pharmacoeconomics. 2001; 19(10):983-1002.
PMID: 11735669
DOI: 10.2165/00019053-200119100-00002.
Pharmacokinetics of antifungal agents in onychomycoses.
Debruyne D, Coquerel A
Clin Pharmacokinet. 2001; 40(6):441-72.
PMID: 11475469
DOI: 10.2165/00003088-200140060-00005.
Onychomycosis in the elderly.
Gupta A
Drugs Aging. 2000; 16(6):397-407.
PMID: 10939306
DOI: 10.2165/00002512-200016060-00002.
